New treatment option for Sarcopenia
Official title Regime for Vitamin D Maintenance in Post-Operative Patients
ClinicalTrials.gov ID: NCT06708741
What this study is testing
What is Vitamin D?
Vitamin D is an investigational medicine, given as a monthly pill taken by mouth, being studied as a potential treatment for sarcopenia.
Also referred to as D-cure.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Vitamin D plays a significant part calcium and phosphate haemostasis, thus, intrinsically critical for bone health. Increasing evidence also reveal that insufficient serum vitamin D levels also result in poor muscle health with such individuals having a compromised muscle building potential (4 times slower muscle building).
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Serum 25-hydroxyvitamin D levels between 30-50ng/ml at 4-6 weeks after operation
- aged 21-65 years
- ability to provide informed consent
- accepts to take vitamin D supplements post-operatively and
- have their serum vitamin D levels checked periodically.
You likely can't join if
- They have undergone minor procedures (Table code \<4a)
- have a history of chronic kidney disease/end staged renal failure
- have previous history of ureteric/kidney stones
- known hyperparathyroidism
- are non-ambulatory independently
- have had known allergies to the commercially available high dose vitamin D formulations.
See the full eligibility criteria
- Serum 25-hydroxyvitamin D levels between 30-50ng/ml at 4-6 weeks after operation
- aged 21-65 years
- ability to provide informed consent
- accepts to take vitamin D supplements post-operatively and
- have their serum vitamin D levels checked periodically.
- They have undergone minor procedures (Table code \<4a)
- have a history of chronic kidney disease/end staged renal failure
- have previous history of ureteric/kidney stones
- known hyperparathyroidism
- are non-ambulatory independently
- have had known allergies to the commercially available high dose vitamin D formulations.
- Vulnerable personnel would be excluded from the study
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.